Rechercher

4th edition of The promises of Treg and Interleukin-2 therapies

21 juil.

1 min de lecture

The 4th edition of The promises of Treg and Interleukin-2 therapies will take place 21–24 October 2026 at the International Conference Center, Sorbonne University in Paris.

Registration is open. https://www.il2-2026.com/

Many key opinion leaders have already confirmed their participation as speakers. Stay informed by checking our official website for the latest updates!

Posts récents

Voir tout

The 2nd annual meeting took place from September 4-5, 2025 in Trieste

ILTOO Pharma welcomes the publication of MIROCALS Phase IIb Trial Results in The Lancet, demonstrating Safety and Efficacy of Low-Dose IL-2 in ALS

Paris, France – May 10, 2025 – ILTOO Pharma is pleased to welcome the publication in The Lancet of the results from the MIROCALS phase IIb clinical trial ( Access the MIROCALS Trial article in The

Breakthrough from the University of Trieste Enhances Gene Therapy for Cardiovascular Diseases

The research group led by Serena Zacchigna at the University of Trieste has found a new way of improving gene therapy for cardiovascular diseases by enhancing the efficiency of gene transfer to cardia

Commentaires